More from report
In Asia-Pacific, India continues to drive the area's growth, accounting for approximately 45% of it; Australia, New Zealand, South Africa, Vietnam, and China also contribute to the area's very strong growth.
Perhaps invest in getting Stelfonta into India, China, South East Asia? TT already being used in human trials in India..
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-777
-
- There are more pages in this discussion • 539 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)